Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program's benefits.
Healthcare Dive published a clinical update in Research Highlights on 21 Apr 2026.
The item focuses on Providers push back on 340B rebate model.
Review the original article for the full source wording and details.